Financhill
Buy
77

SSII Quote, Financials, Valuation and Earnings

Last price:
$7.0000
Seasonality move :
5.87%
Day range:
$5.0000 - $7.0000
52-week range:
$0.3200 - $8.5000
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1,178.01x
Volume:
1.2K
Avg. volume:
1.8K
1-year change:
20.69%
Market cap:
$377.2M
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    SS Innovations International has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of --, SS Innovations International has an estimated downside of -- from its current price of $7.0000.
  • Price Target Upside
    According to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $7.0000.

Fair Value

  • According to the consensus of 0 analysts, SS Innovations International has -- downside to fair value with a price target of -- per share.

SSII vs. S&P 500

  • Over the past 5 trading days, SS Innovations International has overperformed the S&P 500 by 61.9% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • SS Innovations International does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • SS Innovations International has grown year-over-year revenues for 0 quarters straight. In the most recent quarter SS Innovations International reported revenues of --.

Earnings Growth

  • SS Innovations International has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SS Innovations International reported earnings per share of --.
Enterprise value:
379.9M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-264.56x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2020-12-31 2021-12-31 2022-12-31 2021-12-31 2022-12-31
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -$1.1M -$1.4M -$2.4M -$276.4K -$1.3M
EBITDA -$1.1M -$1.5M -$2.2M -$350.7K -$1M
Diluted EPS -$0.50 -$0.60 -$0.47 -$0.10 -$0.20
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Balance Sheet
Current Assets $41.6K $34.8K $163K $408.1K $4.4M
Total Assets $145.4K $132.5K $317.9K $428.6K $4.4M
Current Liabilities $368.5K $1.2M $1.2M $287.3K $4.1M
Total Liabilities $368.5K $1.2M $1.2M $287.3K $4.1M
Total Equity -$223K -$1.1M -$869.1K $141.3K $320.2K
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2020-12-31 2021-12-31 2022-12-31 2021-12-31 2022-12-31
Cash Flow Statement
Cash Flow Operations -$90.5K -$363K -$1.4M -$114.6K -$1.1M
Cash From Investing -$44K $38.2K -$3M $26K -$1.9M
Cash From Financing $266.8K $569.9K $5.4M $289.2K $3.9M
Free Cash Flow -$94.5K -$363K -$1.4M -$114.6K -$1.1M
SSII
Sector
Market Cap
$377.2M
$45.6M
Price % of 52-Week High
82.35%
45.55%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
20.69%
-31.35%
Beta (5-Year)
-54.576
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $4.8650
200-day SMA
Buy
Level $4.1189
Bollinger Bands (100)
Buy
Level 2.4833 - 4.6233
Chaikin Money Flow
Buy
Level 552.1K
20-day SMA
Buy
Level $4.2835
Relative Strength Index (RSI14)
Buy
Level 89.5609
ADX Line
Buy
Level 6.5344
Williams %R
Sell
Level 0
50-day SMA
Buy
Level $3.8318
MACD (12, 26)
Buy
Level 0.5078
25-day Aroon Oscillator
Buy
Level 76
On Balance Volume
Sell
Level -61K

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

SS Innovations International Inc, formerly Avra Medical Robotics Inc develops medical-surgical devices. SSII’s product range includes its proprietary SSi Mantra surgical robotic system  and SSi Mudra, its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. It is a medical robotics company developing a fully autonomous medical robotic system using proprietary software which integrates Artificial Intelligence and Deep Learning, or machine learning. By using an AI and DL-enhanced software program, the company is creating an intelligent robotic system that it believes can robotize a wide range of medical procedures currently being performed by human  hands. SSII’s business operations are headquartered in India.

Stock Forecast FAQ

In the current month, SSII has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SSII average analyst price target in the past 3 months is --.

  • Where Will SS Innovations International Stock Be In 1 Year?

    According to analysts, the consensus estimate is that SS Innovations International share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About SS Innovations International?

    Analysts are divided on their view about SS Innovations International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SS Innovations International is a Sell and believe this share price will rise from its current level to --.

  • What Is SS Innovations International's Price Target?

    The price target for SS Innovations International over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is SSII A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for SS Innovations International is a Buy. 0 of 0 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of SSII?

    You can purchase shares of SS Innovations International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SS Innovations International shares.

  • What Is The SS Innovations International Share Price Today?

    SS Innovations International was last trading at $7.0000 per share. This represents the most recent stock quote for SS Innovations International. Yesterday, SS Innovations International closed at $7.0000 per share.

  • How To Buy SS Innovations International Stock Online?

    In order to purchase SS Innovations International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Sell
40
MSTR alert for Dec 24

MicroStrategy [MSTR] is down 8.7% over the past day.

Sell
26
NUTX alert for Dec 24

Nutex Health [NUTX] is up 9.77% over the past day.

Sell
48
VRNA alert for Dec 24

Verona Pharma PLC [VRNA] is up 7.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock